Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Akero Therapeutics Inc. logo

Akero Therapeutics Inc.

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

45.62
 
USD
  
0.26
  
(0.57%)
Optionable: Yes  Market Cap: 2,855 M  90-day average vol: 699,756

Previous close: 45.36  Open: 45.59  Bid: 45.6  Ask: 48.68
52 week range    
26.37   
   58.38
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Wednesday 27th September 2023
38
MarketXLS Rank
50
Value
30
Technical
34
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0 B-2.52.03

OTLC

0 B-1.90.17

OVAT-CA

Financials

AKRO Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22
Amortization-204000.0
Basic EPS from continuing operations-2.89
Basic EPS total-2.89-2.87
Basic weighted shares outstanding15 M31 M35 M39 M
Diluted EPS total-2.9-5.04-2.89-2.87
Diluted normalized net income/share-2.9-5.04-2.89
Diluted weighted shares outstanding15 M31 M35 M39 M
GainOnSaleOfSecurity-6000.03000.0-24000.064000.0
GeneralAndAdministrativeExpense9 M15 M19 M30 M
Income before tax-44 M-79 M-101 M-112 M
Income taxes-688000.021 M-31 M-42 M
InterestExpenseNonOperating739000.0
MiscOtherSpecialCharges2 M947000.0109000.04 M
Net income from total operations-44 M-79 M-101 M-112 M
NetIncomeCommonStockholders-44 M-79 M-101 M-112 M
NetIncomeContinuousOperations-44 M-79 M-101 M-112 M
NetNonOperatingInterestIncomeExpense-739000.0
Operating income-46 M-80 M-101 M-115 M
Operating income before depreciation (EBITDA)-44 M-79 M-100 M-111 M
OperatingExpense46 M80 M101 M-115 M
Other income net-2 M-950000.0-85000.0-4 M
OtherGandA9 M15 M19 M30 M
OtherOperatingExpenses-237000.0-407000.0-603000.0-746000.0
RentAndLandingFees-305000.030 M
Research & development expense37 M65 M82 M85 M
ResearchExpense37 M65 M82 M85 M
SalariesAndWages-2 M-6 M-10 M-23 M
Selling Gen & administrative expense9 M15 M19 M30 M
Total Income available for interest expense (EBIT)-44 M-79 M-101 M-111 M
Total common shares outstanding29 M35 M35 M47 M
Total net income-44 M-79 M-101 M-112 M
Total ordinary shares56 M56 M56 M56 M
TotalExpenses46 M80 M101 M-115 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and Templates.
Get started today